Foreigners seeking visas to live in the U.S. might be rejected if they have certain medical conditions, including diabetes or ...
Echo Kopplin wants South Dakota’s leaders to know that money from a new $50 billion federal rural health fund should help residents with limited transportation options. Kopplin, a physician assistant ...
Echo Kopplin wants South Dakota’s leaders to know that money from a new $50 billion federal rural health fund should help residents with limited transportation options. Kopplin, a physician assistant ...
Eli Lilly and Novo are preparing to announce new drug pricing deals with the White House, including for their blockbuster weight loss drugs. Blackstone Life Sciences will pay Merck $700 million for ...
Trump’s Lilly-Novo deal; Metsera takeover bids are raised; FDA releases second round of national priority vouchers. President Donald Trump struck a deal with Eli Lilly and Novo Nordisk to lower the ...
Small-business owners and their employees are worried about their health care and their livelihoods as insurance prices surge.
More than two dozen Democrats in the House are pressing the Trump administration to reverse a new policy that makes it harder for male veterans with breast cancer to get health coverage.
Trump to announce Lilly, Novo drug pricing deals; FDA approved a pricey drug over reviewer concerns; Novo’s new obesity pill.
The new reporting segment comprises PR and public affairs firms Allison, Hunter, Consulum, HarrisX, SKDK, Sloane & Company and Targeted Victory.
To read yesterday’s edition of Five things for pharma marketers to know, click here.
Recursion announced Najat Khan, PhD, currently chief R&D and commercial officer and a board member, will succeed co-founder and CEO Chris Gibson, PhD as CEO and president. Khan will also continue in ...
President Donald Trump’s push to eliminate a federal disaster preparedness program threatens a fund used by state health systems from Republican-led Texas to the Democratic stronghold of California.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results